We also found diffuse gliomas with high-expression SYK consistently exhibited higher immune and stromal scores, compared with those with low-expression SYK in the four cohorts (p < 0.05, Figures 4G–J), which indicated SYK might be involved in regulating the immune and stromal cells in the tumor microenvironment. The gene discussed is SYK; the disease is neoplasm.